Drug Type Virus-like particle vaccine, Therapeutic vaccine |
Synonyms Anti-nicotine immunotherapy, Anti-nicotine virus-like particle vaccine, Immunodrug nicotine addiction vaccine + [7] |
Target |
Action antagonists |
Mechanism Nicotinic receptors antagonists(Nicotinic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nicotine Dependence | Phase 2 | Switzerland | 01 Dec 2003 | |
Smoking Cessation | Phase 2 | United States | - | - |
Smoking Cessation | Phase 2 | Germany | - | - |
Smoking Cessation | Phase 2 | Switzerland | - | |
Tobacco Use Disorder | Phase 2 | - | - | |
Tobacco Use Disorder | Phase 2 | - | - |